Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staphylococcus aureus antibiotic resistance

P S Pegram

    American Family Physician
    |September 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Multiple-drug-resistant Staphylococcus aureus, or MRSA, is a growing threat in hospitals due to its rapid spread and resistance to antibiotics. Vancomycin remains a key treatment option for these challenging MRSA infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.

    AIDS research and human retroviruses·2008
    Same author

    Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy.

    Journal of acquired immune deficiency syndromes (1999)·2000
    Same author

    Respiratory distress associated with zanamivir.

    The New England journal of medicine·2000
    Same author

    Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1996
    Same author

    Cryptococcus neoformans myositis in a patient with AIDS.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1995
    Same author

    Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.

    AIDS (London, England)·1995
    Same journal

    For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

    American family physician·2026
    Same journal

    Nausea and Vomiting During Pregnancy.

    American family physician·2026
    Same journal

    Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

    American family physician·2026
    Same journal

    Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

    American family physician·2026
    Same journal

    Overscreening Leads to Overdiagnosis of MASLD.

    American family physician·2026
    Same journal

    Type 2 Diabetes: Outpatient Insulin Management.

    American family physician·2026
    See all related articles

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Rising prevalence of multiple-drug-resistant Staphylococcus aureus (MRSA) strains.
    • Clinical challenges posed by MRSA colonization, infection, and hospital-acquired infections.
    • Limitations of traditional antistaphylococcal antibiotics.

    Observation:

    • MRSA exhibits rapid hospital spread and colonization capabilities.
    • Diminished sensitivity of MRSA to conventional antibiotics like penicillinase-resistant penicillins and cephalosporins.
    • Occasional heteroresistance to aminoglycosides.

    Findings:

    • Vancomycin demonstrates efficacy against MRSA.
    • Heteroresistance patterns necessitate careful antibiotic selection.
    • Vancomycin re-emerges as a critical therapeutic agent.

    Related Experiment Videos

    Implications:

    • Need for alternative treatment strategies for MRSA infections.
    • Importance of vancomycin in managing infections caused by resistant pathogens.
    • Potential impact on hospital infection control protocols and antibiotic stewardship.